OrthoPediatrics Corp.

NASDAQ: KIDS · Real-Time Price · USD
18.95
-0.18 (-0.94%)
At close: Aug 15, 2025, 2:50 PM

OrthoPediatrics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
220.73M 212.45M 204.73M 189.67M 175.07M 161.83M 148.73M 142.11M 137.09M 130.46M 122.29M 116.11M 106.24M 100M 98.05M 92.16M 89.29M 76.18M
Cost of Revenue
62.83M 62.55M 65.94M 65.21M 59.72M 52.47M 42.96M 36.35M 36.39M 34.8M 31.63M 28.59M 26.05M 24.36M 24.65M 21.72M 19.76M 17.04M
Gross Profit
157.91M 149.91M 138.79M 124.46M 115.35M 109.36M 105.77M 105.76M 100.7M 95.66M 90.66M 87.52M 80.18M 75.64M 73.4M 70.44M 69.53M 59.14M
Operating Income
-32.8M -30.78M -29.52M -29.02M -27.96M -27.88M -26.75M -26.99M -25.84M -24M -21.79M -19.04M -19.33M -18.44M -18.02M -25.21M -24.06M -28.23M
Interest Income
n/a n/a n/a 303K 303K 303K 513K 271K 271K 271K 61K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-43.07M -42.06M -41.93M -32.42M -27.03M -24.27M -21.31M -22.31M -4.17M -1.65M -3.69M 4.04M -12.84M -16.11M -17.39M -31.96M -34.01M -39.41M
Net Income
-41.76M -40.68M -37.82M -28.44M -25.12M -21.97M -20.97M -22.13M 998K 3.55M 1.26M 9.18M -11.56M -14.98M -16.26M -30.34M -32.69M -38.38M
Selling & General & Admin
180.66M 175.04M 167.09M 157.9M 146.94M 135.84M 126.82M 122.29M 117.23M 111.39M 104.44M 98.97M 92.83M 87.82M 85.88M 83.32M 81.48M 75.72M
Research & Development
10M 10.39M 11.03M 10.87M 10.68M 10.92M 10.2M 9.48M 9.3M 8.26M 8.01M 7.59M 6.68M 6.26M 5.54M 5.99M 5.76M 5.32M
Other Expenses
5.49M 5.37M 5.39M 758K 758K 1.17M 1.14M 160K 160K -129K -24K 105K 105K 105K 160K 160K 38K -83K
Operating Expenses
196.15M 186.13M 173.8M 153.48M 142.33M 136.26M 131.54M 131.77M 126.54M 119.65M 112.45M 106.56M 99.52M 94.08M 91.43M 89.3M 87.24M 81.03M
Interest Expense
3.96M 3.11M 2.62M 1.3M 919K 952K 881K 881K 1.57M 2.49M 2.49M 2.88M 2.72M 2.08M 2.25M 2.48M 2.94M 3.76M
Selling & Marketing Expenses
69.21M 66.7M 64.3M 59.95M 56.78M 53.35M 51.4M 49.91M 48.24M 47.51M 45.05M 44.09M 42.04M 40.48M 39.67M 39.12M 38.49M 33.24M
Cost & Expenses
258.98M 248.68M 239.74M 218.69M 202.05M 188.73M 174.5M 168.12M 162.93M 154.46M 144.08M 135.15M 125.57M 118.44M 116.07M 111.02M 107M 98.07M
Income Tax Expense
-1.31M -1.38M -4.11M -3.98M -1.91M -2.29M -338K -174K -5.17M -5.2M -4.95M -5.14M -1.29M -1.13M -1.13M -1.61M -1.32M -1.03M
Shares Outstanding (Basic)
23.35M 23.23M 23.17M 23.17M 23.15M 22.82M 22.76M 22.76M 22.7M 22.51M 22.47M 21.15M 19.79M 19.37M 19.3M 19.29M 19.28M 19.2M
Shares Outstanding (Diluted)
23.35M 23.23M 23.17M 23.17M 23.15M 22.82M 22.76M 22.76M 22.7M 22.51M 22.47M 21.3M 19.79M 19.37M 19.3M 19.29M 19.28M 19.2M
EPS (Basic)
-1.79 -1.75 -1.63 -1.23 -1.09 -0.96 -0.92 -0.98 0.10 0.21 0.04 0.40 -0.59 -0.77 -0.84 -1.57 -1.7 -2.05
EPS (Diluted)
-1.79 -1.75 -1.63 -1.23 -1.09 -0.96 -0.92 -0.98 0.09 0.20 0.03 0.39 -0.59 -0.77 -0.84 -1.57 -1.7 -2.05
EBITDA
-16.74M -10.06M -10.46M -15.43M -11.43M -9.33M -9.38M -7.16M 10.68M 13.37M 14.68M 21.78M 4.16M -462K -4.46M -19.3M -21.19M -26.48M
EBIT
-23.37M -29.16M -29.55M -31.14M -26.13M -23.34M -22.21M -23.26M -4.44M -1M 1.2M 9.39M -7.66M -11.56M -15.14M -29.48M -31.07M -35.65M
Depreciation & Amortization
14.32M 19.1M 19.08M 20.57M 19.56M 18.86M 17.68M 16.04M 15.06M 14.31M 13.42M 12.39M 11.82M 11.1M 10.68M 10.18M 9.87M 9.17M